Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Revenue (2017 - 2025)

Historic Revenue for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to $150.9 million.

  • Organogenesis Holdings' Revenue rose 3098.45% to $150.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $465.2 million, marking a year-over-year increase of 223.72%. This contributed to the annual value of $482.0 million for FY2024, which is 1129.03% up from last year.
  • According to the latest figures from Q3 2025, Organogenesis Holdings' Revenue is $150.9 million, which was up 3098.45% from $101.0 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Revenue ranged from a high of $150.9 million in Q3 2025 and a low of $86.7 million during Q1 2025
  • Moreover, its 5-year median value for Revenue was $115.2 million (2024), whereas its average is $114.3 million.
  • In the last 5 years, Organogenesis Holdings' Revenue soared by 7864.85% in 2021 and then plummeted by 2244.34% in 2025.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Revenue stood at $127.9 million in 2021, then decreased by 9.65% to $115.5 million in 2022, then dropped by 13.73% to $99.7 million in 2023, then grew by 27.1% to $126.7 million in 2024, then rose by 19.11% to $150.9 million in 2025.
  • Its Revenue stands at $150.9 million for Q3 2025, versus $101.0 million for Q2 2025 and $86.7 million for Q1 2025.